Exploring CAR T-Cell Therapy for B-Cell Lymphomas

This chapter examines the applications of anti-CD19 CAR T-cell therapy in treating acute lymphocytic leukemia and relapsed B-cell lymphomas, with a special emphasis on follicular lymphoma. It analyzes clinical studies showcasing treatment efficacy, response rates, and the impact of patient cohorts and treatment protocols on outcomes.